BRIDGEBIO PHARMA, INC. (BBIO)
📋 RANDAL SCOTT (Director) plans to sell 22K shares of BridgeBio Pharma, Inc. (at $79.86 each, total $1.7M) Filed: Aug 17, 2026 | ID: 008246
📋 RANDAL SCOTT (Director) plans to sell 22K shares of BridgeBio Pharma, Inc. (at $79.86 each, total $1.7M) Filed: Aug 17, 2026 | ID: 008246
📋 Form 144 Filing: RANDAL SCOTT
Company: BridgeBio Pharma, Inc.
Filing Date: 2026-08-17
Relationship: Director
Planned Sale Details:
Additional Information: